The paper reports the results of a computational study on compounds capable of inhibiting the prion-like infection mechanism of superoxide dismutase-1 (SOD1) mutants, which are the basis of amyotrophic lateral sclerosis (ALS). The gene discussed is SOD1; the disease is infection.